Deprescribing in the Spotlight: What RFK Jr.’s Announcement Means for Nursing, Patients, and Families
In May 2026, new national attention was placed on deprescribing following a federal announcement led by Robert F. Kennedy Jr. and the U.S. Department of Health and Human Services (HHS).
At the center of this initiative is a growing concern:
Are we over-relying on medications—especially in mental health—and not reassessing them over time?
The answer, according to emerging policy and research, is complex—but clear:
➡️ Medications save lives
➡️ But they are not always meant to be lifelong
➡️ And without reassessment, they can create harm
What Was Announced
The new federal action plan announced by RFK Jr. focuses on:
Reducing psychiatric overprescribing, especially antidepressants
Promoting deprescribing when clinically appropriate
Expanding non-medication treatments (therapy, lifestyle, social support)
Requiring informed consent and shared decision-making
Supporting clinicians with training and reimbursement for deprescribing care
Importantly, this is not a directive to stop medications.
Instead, it represents a shift in philosophy:
Medications should be continuously evaluated, not automatically continued.
Why This Impacts Both Youth and Older Adults
This initiative is unique because it targets both ends of the age spectrum:
Youth & Adolescents
Rising use of antidepressants and psychiatric medications
Concerns about:
Long-term effects
Withdrawal symptoms
Informed consent in developing patients
The federal plan specifically highlights children and adolescents as a priority population
Older Adults
High rates of polypharmacy (multiple medications)
Increased risk of:
Falls
Delirium
Drug interactions
Hospital readmissions
Evidence consistently shows deprescribing in older adults can:
Reduce adverse drug events
Improve cognition and function
Lower hospitalization risk
What the Evidence Says About Deprescribing
Deprescribing is not a trend—it is an evidence-based clinical practice.
Key Findings from Research:
Many medications are continued without ongoing indication
Polypharmacy is linked to increased morbidity and mortality
Structured deprescribing:
Improves safety
Enhances quality of life
Reduces healthcare utilization
Clinical frameworks like:
Beers Criteria
Deprescribing.org evidence-based algorithms
…are now being referenced alongside federal guidance.
The Critical Risk: Deprescribing Done Poorly
While deprescribing has benefits, the biggest clinical risk is not the medication—it’s how it’s stopped.
Improper deprescribing can lead to:
Withdrawal symptoms
Symptom rebound
Mental health destabilization
Increased suicide risk in vulnerable populations
This is why federal guidance emphasizes:
Gradual tapering
Close monitoring
Individualized care plans
The Nursing Impact: A Major Shift in Clinical Responsibility
Although these guidelines are directed at physicians, nurses will carry much of the real-world impact.
1. Nurses Become Central to Monitoring
Deprescribing is not a one-time decision—it is a process.
Nurses will:
Observe day-to-day changes
Detect early warning signs
Monitor for withdrawal or relapse
2. Medication Review Becomes Continuous
Nursing care will increasingly include:
Ongoing medication reconciliation
Identifying medications that “no longer make sense”
Escalating concerns to providers
3. Communication & Education Expand
Patients often ask:
“Why are we stopping this?”
“Is this safe?”
Nurses will be responsible for:
Translating complex decisions into clear guidance
Supporting adherence to taper plans
Reducing fear and confusion
4. Nurses Become Advocates in a Fragmented System
One of the biggest problems identified in both research and policy: Medications are started—but rarely revisited
Nurses are often the only clinicians who:
See the patient consistently
Understand real-life outcomes
Can connect the dots across providers
Why This Matters in the Home Setting
Deprescribing requires:
Time
Observation
Continuity
These are often missing in traditional healthcare models.
This creates a gap between:
➡️ Provider decision
➡️ Real-world patient experience
And that gap is where complications—and readmissions—happen.
The ClearPath Perspective
At ClearPath Concierge & Private Duty Nursing, we see this every day:
Patients discharged with:
New medications
Limited explanation
No clear follow-up
Deprescribing isn’t just about reducing medications.
It’s about ensuring every medication still serves a purpose.
That requires:
Clinical oversight
Ongoing reassessment
Advocacy at home
Final Thoughts
The recent federal deprescribing initiative signals a major shift in healthcare:
➡️ From automatic prescribing
➡️ To intentional, evidence-based medication use
But success will depend on more than policy.
It will depend on:
Careful monitoring
Patient-centered communication
Strong nurse involvement
Because in the end:
Deprescribing is not about taking something away.
It’s about making care safer, clearer, and more aligned with the patient.
From a personal standpoint, I hope we also increase access to mental health resources for all ages without 6-12 month waits to access clinicians/resources.
I also strongly believe in medication reconciliation along with program like the Belew Drugs Precision Pak Program which makes monitoring side effects and med reconciliation easier and safer.